C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Consensus Rating of "Hold" by Analysts
C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) has received an average rating of “Hold” from the seven analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average […]